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Abstract
OBJECTIVE: To systematically assess the clinical ef-
fectiveness of Chinese medicines for prevention
and treatment of radiation esophagitis by me-
ta-analysis.
METHODS: The articles were mainly retrieved from
the "CHKD (China Hospital Knowledge Database)
periodical full text databank", the "China periodical
full text databank", the "CHKD doctor's and Master's
degree student full text databank", and the "China
doctor's degree student thesis databank", and they
were selected according to the literature selection
standard. The effects of Chinese medicines and
Western medicines on radiation esophagitis were
compared by meta-analysis.
RESULTS: Based on 13 articles, we found that the
effectiveness of Chinese medicines for prevention
and treatment of radiation esophagitis was superi-
or to Western medicines, with no obvious side ef-
fects. Meta-analysis showed that the total odds ra-
tio was 0.426 and the 95% confidence interval was
0.368, 0.493.
CONCLUSION: Chinese medicines are superior to
Western medicines in preventing and treating radi-
ation esophagitis. However, some methodological
problems in the literature may have affected the au-
thenticity of the results. Therefore, more rigorous,
multi-central, randomized controlled trials with a
large sample size should be designed to obtain a
more reliable conclusion.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
The morbidity of malignant tumors has tended to in-
crease yearly in these 10 years. Radiotherapy is one of
the main therapeutic treatments for tumors in the
chest, such as lung cancer, carcinoma of the esophagus
and mediastinal tumors, and it plays an important role
in controlling the advance of malignant tumors. How-
ever, in radiotherapy of tumors in the chest, the radia-
tion field unavoidably often spreads to the esophagus,
inducing acute esophagitis. This mainly manifests as
odynophagia, which affects food intake. For patients
with mild esophagitis, food intake is not sufficient and
for severe cases, it leads to malnutrition and electrolyte
disturbance, even when treatment is suspended, affect-
ing the therapeutic effect of the radiotherapy[1]. In re-
cent years, clinically, chemotherapy has been common-
ly combined with radiotherapy to treat cancers of the
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esophagus and lung to achieve better anti-cancer ef-
fects. However, according to statistical results,
20%-30% of patients suffer from severe acute esophagi-
tis, limiting the treatment and severely influencing the
patient's quality of life, even leading to or accelerating
death[2]. Presently, Western medicine adopts expectant
treatment with the digestive tract mucosal protective
agent, Smecta, as well as anti-inflammatory agents and
analgesics, such as antibiotics, anesthetics, and gluco-
corticoid hormones., Unfortunately, because of side ef-
fects, such as inhibition of immune function, aggregat-
ing or inducing infection, colonial imbalance, and
hemorrhage of the digestive tract, they are unfavorable
for the clinical population and long term use. Chinese
medicines can be used as an auxiliary treatment. These
medicines can prevent radiation esophagitis and can
strengthen resistance of the body and have anti-cancer
effects, increasing the patient's quality of life and pro-
longing the survival period, which conforms to the to-
tal goal of combined treatment of tumors. However, it
is unclear whether Chinese medicines can be used as
standard medicines for preventing and treating radia-
tion esophagitis, and their therapeutic effect and safety
are not well understood. Therefore, the authors adopt-
ed the method of evidence-based medicine (meta-analy-
sis) to investigate these issues.
METHODS
Retrieval tactics
The research range was limited to medical literature
publically published in medical periodicals in China be-
tween January 1999-December 2010, including the
"CHKD periodical full text databank", the "China pe-
riodical full text databank", the "CHKD doctor's and
Master's degree student full text databank", and the
"China doctor's degree student thesis databank". "Radi-
ation esophagitis" was used as a key word or title for
the first retrieval, and then "prevention and treat-
ment", "treatment", "Chinese drugs", "treatment with
Chinese drugs", and "treatment with Chinese medi-
cine and drugs" were used as key words for the second
retrieval.
Inclusive criteria
Inclusive criteria included the following: 1) main inter-
venient measures were clinically randomized controlled
trials of Chinese medicines for prevention and treat-
ment of radiation esophagitis; 2)there were generally
recognized criteria for diagnosis; 3) forms of prepared
Chinese drugs, including decoctions and pill capsules,
and administration methods, including oral administra-
tion and enema, were not limited; 4) there were gener-
ally recognized criteria for assessing therapeutic effects.
Exclusive criteria
Exclusive criteria included the following: 1) reports
with no cases of a control group; 2) Western medicines
were used for the treatment group and Chinese medi-
cines were used for the control group; 3) Chinese
drugs were used in the treatment group and placebo
was used in the control group; 4) in the treatment
group, there were complex factors, such as acupunc-
ture; 5) descriptive research without statistical analysis.
Quality assessment of methodology
The trials included in this study were assessed by the
Jadad scale[3](1-5 points). The clauses and subclauses in
the scale were involved in assessment of randomization
and methods, blind methods (double blind/single
blind), and detailed reports on excluding research sub-
jects. A total score of 1-2 was regarded as research of
low quality and 3-5 was regarded as high quality.
Methods for assessment of therapeutic effects
With regard to RTOG (Radiation Therapy Oncology
Group)and EORTC radioactive toxicity criteria, scal-
ing criteria for acute radiation esophagitis were divided
into 0-4 grades as follows[8]: 0: no symptoms; 1: mild
dysphagia or odynophagia, and superficial anesthesia,
non-anesthetic analgesia or a semiliquid diet was neces-
sary; 2: moderate dysphagia or odynophagia, and anes-
thetic analgesia or a semiliquid diet was necessary; 3: se-
vere dysphagia or odynophagia, complicated by dehy-
dration or a body mass decreasing over 15%, and sup-
plement of nutrition by nasal feeding or venous trans-
fusion was necessary; and 4: complete obstruction, and
ulcer and perforation or fistulous formation. Among
them, grades 0 and 1 were regarded as mild inflamma-
tion and grades 2, 3, and 4 as moderate and severe in-
flammation. The occurrence rate of moderate and se-
vere inflammation was used for determining therapeu-
tic effects.
Statistical method
RevMan 4.2 software package supplied by the Co-
chrane co-network was used for data analysis. For the
enumeration data, RR (Risk Ratio) was selected for cal-
culation of the 95% CI, and Chi-square analysis was
used for heterogeneity of various test results. If there
was no heterogeneity, a fixed effect model was selected
for meta-analysis. Conversely, a randomized effect
model was selected for meta-analysis. Potential publish-
ing deviation was analyzed with an inverted funnel
plot.
RESULTS
Analysis of the literature and assessment of quality
Seventeen papers possibly conforming to the inclusive
criteria were assessed by reading abstracts of the litera-
ture. The full text was then read and 4 papers were ex-
cluded. Finally, 13 papers were included in the study
(Table 1). The reasons for excluding the literature were
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as follows: intervening measures had mixed factors in 2
studies[4,5]; chemotherapeutic drugs and treatment dura-
tion in the treatment group were greatly different to
other previous literature in 1 study[6]; and 1 study[7] was
replicated in the literature. All of the 13 papers selected
were ≥2 points in the Jadad scale, and the grouping
method was "random" and the treatment duration be-
gan from radiotherapy to the end of radiotherapy.
Table 1 Data of inclusive literature of clinical research on Chinese drugs for preventing and treating radiation esophagitis
Author
LU JZ,
et al.[9]
XU LC,
et al.[10]
WU D,
et al.[11]
YAOWH[12]
CHEN ZM,
et al.[13]
HE FX[14]
FANG P,
et al.[15]
CUI DL,
et al.[16]
ZENG BR,
et al.[17]
ZHAO JB,
et al.[18]
HUANG Y,
et al.[19]
WANGXZ[20]
ZHOU X,
et al.[21]
Intervening
measure
Treatment
group
Modified Zhuye
Shigao Decoction
Modified Qige San
Chinese drugs for
clearing away heat and
toxic material
Shashen Maidong
Decoction
Shuandi Mixureal.
Shunshi Decoction
Yangyin Jiedu
Decoction
Method for nourishing
yin and removing toxic
material
Yangyin Qingre
Shengji Decoction
Yinqiao Qingdai
Decoction
Chinese drugs
Decoction and soft
extract of Chinese
drugs
extract of Chinese
drugs
Control
group
Smecta
Procaine,
dexamethasone,
gentamicin
Saline, sodium
bicarbionate,
lidocaine
Saline ,
gentamicin,
lidocaine
Procaine,
dexamethasone,
gentamicin
Saline , lidocaine,
dexamethasone,
gentamicin
Vitamin C tablet,
prednisone tablet ,
amoxicillin capsule
Gentamicin,
mannitol
Saline, gentamicin,
lidocaine
Saline, lidocaine,
dexamethasone,
gentamicin
Mannitol,
dexamethasone,
gentamicin
Vitamin C tablet,
gentamicin
Saline, lidocaine,
dexamethasone,
gentamicin
Treatment
group
Mild
Inflammation
68
20
34
28
29
127
25
20
17
32
15
87
16
Moderate
-severe
Inflammation
12
8
2
12
11
10
5
17
13
10
23
3
29
Total
cases
80
28
36
40
40
137
30
37
30
42
38
90
45
Control
group
Mild
Inflammation
19
7
23
16
15
86
8
13
9
14
5
58
12
Moderate-
severe
Inflamma-
tion
21
21
11
21
25
44
22
29
21
45
27
32
31
Total
cases
40
28
34
37
40
130
30
42
30
59
32
90
43
Assessment of therapeutic effects of Chinese drugs for
preventing and treating radiation esophagitis
The 13 papers all reported the effects of Chinese drugs
and Western drugs for preventing and treating radia-
tion esophagitis, and the results were compared be-
tween the 2 groups by meta-analysis (Figure 1). Statisti-
cal analysis showed that the heterogeneity test was P<
0.0001 which suggested that there was heterogeneity
among the results of the studies. This difference was
mainly induced by differences in the follow-up time,
treatment dosage and dosage form of the drug. A ran-
dom effects model was then selected. RR was 0.426,
the 95% CI was 0.368, 0.49, and the total effective-
ness was hypothetically tested and it was found that Z=
11.40 (P<0.0001). These results indicated that Chi-
nese drugs had a significantly better effect than West-
ern drugs in preventing and treating radiation esophagi-
tis.
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Figure 1 Meta-analysis of Chinese drugs andWestern drugs for preventing and treating radiation esophagitis.
Publication bias
The essence of meta-analysis is that it is a type of obser-
vational research, and drawing a funnel plot can help
determine publication bias. In this study, a funnel
graph was drawn with the ratio (RR) of the synthetic
therapeutic effects of the treatment group to that of the
control group in the 13 studies as the horizontal coordi-
nate, and the reciprocal of RR as the vertical ordinate
(Figure 1). We observed that the reversed funnel-shape
plot was asymmetrical, indicating that the inclusive lit-
erature in this study showed publication bias. The
main cause of this publication bias is that studies with
negative results are difficult to publish. In addition,
low quality of the methodology, differences between
the test group and the control group in basic data, and
other factors could also lead to asymmetrical distribu-
tion of the inversed funnel plot.
Figure 2 Inversed funnel plot of therapeutic effects of Chi-
nese drugs for preventing and treating radiation esophagitis.
DISCUSSION
This study showed that Chinese medicine for prevent-
ing and treating radiation esophagitis was significantly
better than Western medicines, with no significantly
adverse effects. Previous research has indicated that the
basic pathogenesis of radiation esophagitis is "invasion
of heat toxicity, injuring both Qi and yin", accompa-
nied by blood stasis, blood-dryness, phlegm-dampness,
failure of descending of the stomach-Qi and disorder
of the stomach-Qi. The principle of treatment is clear-
ing away heat and toxic material, nourishing yin and
promoting production of body liquids. Auxiliary treat-
ment includes activating blood circulation and remov-
ing blood stasis, removing heat from the blood and
moistening, resolving phlegm and removing dampness,
regulating the stomach, and lowering the reverse flow
of Qi. Commonly-used recipes are Zhuye Shigao De-
coction, Qige Decoction, Shashen Maidong Decoc-
tion, and Shunshi Decoction. Commonly-used Chi-
nese drugs for clearing away heat and material include
Zhuye (bamboo leaf ), Shigao (Gypsum Fibrosum), Lu-
gen (Rhizoma Phragmitis), Jinyinhau (Flos Lonicerae),
and Lianqiao (Fructus Forsythiae). Drugs for supple-
menting Qi and nourishing yin include Renshen (Ra-
dix Ginseng), Maidong (Radix Ophiopogonis), Sheng-
di (Radix Rehmanniae), Shashen (Radix Adenophorae
Strictae), Xuanshen (Radix Scrophulariae), and Tian-
huafen (Radix Trichosanthis). Drugs for eliminating
dampness and resolving phlegm, lowering the reverse
flow of Qi, and stopping nausea and vomiting include
Chuanbei (Bulbus Fritillariae Cirrhosae) and Banxia
(Rhizoma Pinelliae). Drugs for promoting circulation
of Qi and blood circulation include Yujing (Radix Cur-
cumae) and Danshen (Radix Salviae Militiorrhizae).
Drugs for clearing away heat and toxic material and an-
ti-cancer effects include Baihua Sheshe Cao (Herba
Hedyotis Diffusae) and Banzhilian (Herba Scutellariae
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Barbatae). TCM aims to "prevent diseases" at the be-
ginning of radiation treatment. Simultaneous preven-
tive administration can significantly decrease the mor-
bidity of moderate-severe radiation esophagitis, achieve
good prevention and treatment effects, obtain success-
ful completion of radiotherapy, and improve the quali-
ty of life of the patient.
Our study has the following limitations. 1) Because the
quality of most of the studies included in our me-
ta-analysis was low, and meta-analysis itself also has cer-
tain shortcomings, our conclusion needs to be con-
firmed. In the future, scientifically designed clinical re-
search programs, with multi-central, randomized, dou-
ble blind, controlled trials with a large sample size
should be performed to provide more convincing evi-
dence. 2) In our study, the inversed funnel plot was
clearly asymmetric, indicating that the included litera-
ture showed publication bias. The main cause of this
bias is that studies with negative results are difficult to
publish. In addition, the low quality of methodology
and a small sample size are causes leading to this asym-
metric distribution. 3) The heterogeneity test showed
that 0.05, which is possibly caused by problems in the
implementation of randomization and other aspects,
with a lack of balance between the treatment group
and the control group. Additionally, basic treatments
of the two groups had more changes, there were differ-
ences in drug dosage and therapeutic course in the con-
trol group, and the characteristics of the studies, includ-
ing age, sex proportion, duration of illness, patient's
condition and complications, were also important fac-
tors of variance. 4) In all of the studies, there were no
adverse reactions in the Chinese drug group. Because
of a less test about our study, our results need to be
confirmed. In the future, studies should focus on the
safety of medicines, with more detailed observational
reports and more systematical assessment.
While our meta-analysis showed that Chinese drugs
for preventing and treating radiation esophagitis had a
good clinical effect and no obvious adverse reactions
were found, the quality of the inclusive literature was
low, with publication bias. Therefore, potential thera-
peutic effects remain to be shown by well designed, ran-
domized double blind, placebo, controlled trials. Fu-
ture studies need to be of good scientific research de-
sign with a large sample size, contain multi-central clin-
ical cases, have systematic syndrome differentiation
and assessment of radiation esophagitis, and establish
methods and criteria of syndrome differentiation typ-
ing conforming to TCM syndrome differentiation the-
ories and clinical practice. Strengthening exploration of
objectification and standardization of TCM for pre-
venting and treating radiation esophagitis are required
to provide more convincing evidence for clinical thera-
peutic effects of Chinese drugs.
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